Chan V J, Selzer P M, McKerrow J H, Sakanari J A
Department of Pathology, University of California, San Francisco, CA, USA.
Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):113-7.
The mature form of the cathepsin B-like protease of Leishmania major (LmajcatB) is a 243 amino acid protein belonging to the papain family of cysteine proteases and is 54% identical to human-liver cathepsin B. Despite the high identity and structural similarity with cathepsin B, LmajcatB does not readily hydrolyse benzyloxycarbonyl-Arg-Arg-7-amino-4-methyl coumarin (Z-Arg-Arg-AMC), which is cleaved by cathepsin B enzymes. It does, however, hydrolyse Z-Phe-Arg-AMC, a substrate typically cleaved by cathepsin L and B enzymes. Based upon computer generated protein models of LmajcatB and mammalian cathepsin B, it was predicted that this variation in substrate specificity was attributed to Gly234 at the S2 subsite of LmajcatB, which forms a larger, more hydrophobic pocket compared with mammalian cathepsin B. To test this hypothesis, recombinant LmajcatB was expressed in the Pichia pastoris yeast expression system. The quality of the recombinant enzyme was confirmed by kinetic characterization, N-terminal sequencing, and Western blot analysis. Alteration of Gly234 to Glu, which is found at the corresponding site in mammalian cathepsin B, increased recombinant LmajcatB (rLmajcatB) activity toward Z-Arg-Arg-AMC 8-fold over the wild-type recombinant enzyme (kcat/Km=3740+/-413 M-1.s-1 versus 472+/-72.4 M-1.s-1). The results of inhibition assays of rLmajcatB with an inhibitor of cathepsin L enzymes, K11002 (morpholine urea-Phe-homoPhe-vinylsulphonylphenyl, kinact/Ki=208200+/-36000 M-1. s-1), and a cathepsin B specific inhibitor, CA074 [N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l- prolin e, kinact/Ki=199200+/-32900 M-1.s-1], support the findings that this protozoan protease has the P2 specificity of cathepsin L-like enzymes while retaining structural homology to mammalian cathepsin B.
硕大利什曼原虫组织蛋白酶B样蛋白酶(LmajcatB)的成熟形式是一种由243个氨基酸组成的蛋白质,属于半胱氨酸蛋白酶木瓜蛋白酶家族,与人类肝脏组织蛋白酶B的同源性为54%。尽管与组织蛋白酶B具有高度同源性和结构相似性,但LmajcatB不易水解被组织蛋白酶B酶切割的苄氧羰基-精氨酸-精氨酸-7-氨基-4-甲基香豆素(Z-Arg-Arg-AMC)。然而,它确实能水解Z-苯丙氨酸-精氨酸-AMC,这是一种通常被组织蛋白酶L和B酶切割的底物。基于LmajcatB和哺乳动物组织蛋白酶B的计算机生成蛋白质模型,预计底物特异性的这种差异归因于LmajcatB的S2亚位点的甘氨酸234,与哺乳动物组织蛋白酶B相比,它形成了一个更大、更疏水的口袋。为了验证这一假设,在毕赤酵母表达系统中表达了重组LmajcatB。通过动力学表征、N端测序和蛋白质印迹分析证实了重组酶的质量。将甘氨酸234替换为在哺乳动物组织蛋白酶B相应位点发现的谷氨酸,使重组LmajcatB(rLmajcatB)对Z-Arg-Arg-AMC的活性比野生型重组酶提高了8倍(kcat/Km = 3740±413 M-1·s-1对472±72.4 M-1·s-1)。用组织蛋白酶L酶抑制剂K11002(吗啉脲-苯丙氨酸-高苯丙氨酸-乙烯基磺酰基苯基,kinact/Ki = 208200±36000 M-1·s-1)和组织蛋白酶B特异性抑制剂CA074 [N-(L-3-反式-丙基氨基甲酰氧基环氧乙烷-2-羰基)-L-异亮氨酰-L-脯氨酸,kinact/Ki = 199200±32900 M-1·s-1]对rLmajcatB进行抑制试验的结果支持了这一发现,即这种原生动物蛋白酶具有组织蛋白酶L样酶的P2特异性,同时与哺乳动物组织蛋白酶B保持结构同源性。